Bullish indicating open at $55-$60, IPO prices at $37
MEXICO CITY - ABC Medical (TASE:BLWV) Center in Mexico City will begin piloting Ondine Biomedical’s (AIM:OBI) Steriwave nasal photodisinfection system next month, marking the first hospital deployment of the technology in Mexico, according to a company press release.
The pilot program will target the reduction of surgical site infections and healthcare-associated infections in orthopedic and neurosurgery patients at the private healthcare facility.
Steriwave is a non-antibiotic therapy that uses light activation to decolonize nasal passages. The procedure involves applying a photosensitizer into the nares, followed by illumination with red light, generating a reaction that inactivates bacteria, viruses, and fungi.
"Piloting Steriwave as a first in Mexico reflects our commitment to adopting evidence-based interventions against antimicrobial resistance," said Dra. Roxana Trejo Gonzalez, Director of Infection Control at ABC Medical Center.
The deployment comes as Mexico faces surgical site infection rates nearly double those in the U.S., compounded by rising antimicrobial resistance. Mexico’s healthcare system includes approximately 3,000 private hospitals that perform around 25% of all surgeries annually.
ABC Medical Center, established in 1886, operates two campuses with 850 beds and serves both local patients and international medical tourists.
The Steriwave system has previously been deployed in hospitals in Canada, the UK, and other countries, with studies showing reductions in healthcare-associated infections without evidence of microbial resistance development, according to the company.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.